Marathon Petroleum vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 87)

Marathon Petroleum

LeaderEnergy & Utilities

Enterprise

Findlay OH petroleum refining (NYSE: MPC); largest US refiner 3M barrels/day, CEO Maryann Mannen elected Chairman (Jan 2026), MPLX midstream MLP, Martinez renewable diesel conversion competing with Valero and Phillips 66.

AI VisibilityBeta
Overall Score
A87
Category Rank
#157 of 290
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
93
Perplexity
91
Gemini
91

About

Marathon Petroleum Corporation is a Findlay, Ohio-based petroleum refining and midstream company — publicly traded on the New York Stock Exchange (NYSE: MPC) as an S&P 500 Energy component — operating the largest crude oil refining system in the United States with 13 refineries and approximately 3 million barrels per day of crude oil processing capacity across Texas, Louisiana, Illinois, Michigan, Ohio, North Dakota, California, and Washington, along with a majority ownership interest in MPLX LP (NYSE: MPLX), a midstream pipeline, terminal, and marine vessel MLP that gathers, processes, transports, and stores crude oil, natural gas, and petroleum products. In a defining leadership development, Marathon Petroleum's board elected CEO Maryann T. Mannen as Chairman of the Board effective January 1, 2026, succeeding Michael Hennigan who retired after leading the company through the Speedway divestiture and pandemic recovery — consolidating corporate governance leadership in Mannen following her tenure as CEO during which she managed the company's operations and capital allocation strategy. Marathon Petroleum's large-scale refining system (including the Galveston Bay refinery in Texas City as the largest US refinery at 631,000 barrels/day) processes crude oil into gasoline, diesel, jet fuel, and specialty products distributed through branded Speedway (sold to 7-Eleven in 2021) and independent dealer networks and MPLX's logistics infrastructure.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

87
Overall Score
90
#157
Category Rank
#9
75
AI Consensus
60
stable
Trend
stable
93
ChatGPT
99
91
Perplexity
99
91
Gemini
83
83
Claude
96
93
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.